BXP · Insider Trading
BXP, Inc.
Every open-market purchase and sale reported by BXP officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Joel Klein | Director | A | +552 deriv. | — |
| 2026-10-01 | Tony West | Director | A | +388 deriv. | — |
| 2026-10-01 | Bruce W Duncan | Director | A | +572 deriv. | — |
| 2026-10-01 | William H Walton III | Director | A | +388 deriv. | — |
| 2026-10-01 | Julie Richardson | Director | A | +409 deriv. | — |
| 2026-10-01 | Matthew J Lustig | Director | A | +490 deriv. | — |
| 2026-10-01 | Mary E Kipp | Director | A | +450 deriv. | — |
| 2026-07-01 | Tony West | Director | A | +351 deriv. | — |
| 2026-07-01 | Matthew J Lustig | Director | A | +439 deriv. | — |
| 2026-07-01 | William H Walton III | Director | A | +345 deriv. | — |
| 2026-07-01 | Julie Richardson | Director | A | +364 deriv. | — |
| 2026-07-01 | Mary E Kipp | Director | A | +402 deriv. | — |
| 2026-07-01 | Bruce W Duncan | Director | A | +515 deriv. | — |
| 2026-07-01 | Joel Klein | Director | A | +496 deriv. | — |
| 2026-06-10 | Michael E Labelle | EVP and CFO | Sell | −26,113 | −$1.73M |
| 2026-06-04 | Michael E Labelle | EVP and CFO | C | +23,981 | — |
| 2026-06-02 | Julie Richardson | Director | A | +3,332 deriv. | — |
| 2026-06-02 | Diane J Hoskins | Director | A | +3,332 | — |
| 2026-06-02 | Matthew J Lustig | Director | A | +3,332 deriv. | — |
| 2026-06-02 | Tony West | Director | A | +1,666 | — |
| 2026-06-02 | Bruce W Duncan | Director | A | +3,332 deriv. | — |
| 2026-06-02 | Timothy J Naughton | Director | A | +3,332 | — |
| 2026-06-02 | Joel Klein | Director | A | +3,332 deriv. | — |
| 2026-06-02 | William H Walton III | Director | A | +3,332 deriv. | — |
| 2026-06-02 | Mary E Kipp | Director | A | +3,332 deriv. | — |
| 2026-05-26 | Eric G Kevorkian | SVP, CLO and Secretary | MIXED | −200 | −$131.75K |
| 2026-05-20 | Peter V Otteni | Executive Vice President | Sell | −4,863 | −$287.19K |
| 2026-05-18 | Peter V Otteni | Executive Vice President | C | +4,863 | — |
| 2026-04-01 | Tony West | Director | A | +457 deriv. | — |
| 2026-04-01 | Matthew J Lustig | Director | A | +578 deriv. | — |
| 2026-04-01 | Bruce W Duncan | Director | A | +674 deriv. | — |
| 2026-04-01 | William H Walton III | Director | A | +457 deriv. | — |
| 2026-04-01 | Mary E Kipp | Director | A | +529 deriv. | — |
| 2026-04-01 | Joel Klein | Director | A | +650 deriv. | — |
| 2026-04-01 | Julie Richardson | Director | A | +481 deriv. | — |
| 2026-03-02 | Hilary J. Spann | Executive Vice President | Sell | −5,495 | −$328.00K |
| 2026-02-26 | Hilary J. Spann | Executive Vice President | C | +5,495 | — |
| 2026-02-17 | Douglas T Linde | President | A | +20,973 deriv. | — |
| 2026-02-17 | Bryan J Koop | Executive Vice President | A | +5,501 deriv. | — |
| 2026-02-17 | Owen D Thomas | Chief Executive Officer | A | +35,930 deriv. | — |
| 2026-02-17 | Raymond A Ritchey | Senior EVP | A | +15,163 deriv. | — |
| 2026-02-17 | Michael E Labelle | EVP and CFO | A | +7,736 deriv. | — |
| 2026-02-13 | Owen D Thomas | Chief Executive Officer | MIXED | — | −$73.34K |
| 2026-02-06 | Hilary J. Spann | Executive Vice President | Sell | −1,194 | −$75.59K |
| 2026-02-02 | Donna D Garesche | EVP, Chief HR Officer | A | +3,401 deriv. | — |
| 2026-02-02 | Rodney Diehl | Executive Vice President | A | +8,504 deriv. | — |
| 2026-02-02 | Peter V Otteni | Executive Vice President | A | +7,731 deriv. | — |
| 2026-02-02 | John J Stroman | Executive Vice President | A | +11,597 deriv. | — |
| 2026-02-02 | Michael R. Walsh | SVP & Chief Accounting Officer | A | +4,638 deriv. | — |
| 2026-02-02 | Douglas T Linde | President | A | +52,574 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Douglas T Linde | President | 215,938 | $13.15M |
| Bruce W Duncan | Director | 21,000 | $1.28M |
| Diane J Hoskins | Director | 18,929 | $1.15M |
| Carol B. Einiger | Director | 18,000 | $1.10M |
| Hilary J. Spann | Executive Vice President | 17,832 | $1.09M |
| Raymond A Ritchey | Senior EVP | 14,150 | $861.59K |
| Owen D Thomas | Chief Executive Officer | 12,672 | $771.63K |
| Matthew J Lustig | Director | 10,000 | $608.90K |
| Bryan J Koop | Executive Vice President | 9,751 | $593.78K |
| Timothy J Naughton | Director | 8,601 | $523.71K |
| Tony West | Director | 7,691 | $468.30K |
| Michael E Labelle | EVP and CFO | 5,839 | $355.54K |
| Eric G Kevorkian | SVP, CLO and Secretary | 2,311 | $140.72K |
| Mary E Kipp | Director | 542 | $33.00K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BXP quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.